Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:CMCSA
NasdaqGS:CMCSATelecom

US Stock Market Today: S&P 500 Futures Rise amid Cooling Costs, Resilient Housing Data

The Morning Bull - US Market Morning Update Tuesday, Dec, 16 2025 US stock futures are pointing higher this morning, with contracts tied to the S&P 500 up about half a percent, as investors weigh cooling but still elevated business costs against signs of resilience in housing. The latest New York manufacturing survey slipped back into contraction at minus 3.9, which means factories in that region are pulling back a bit, but it also showed that price pressures are easing, a mild positive for...
NYSE:NUVB
NYSE:NUVBPharmaceuticals

Is Nuvation Bio’s 228.6% 2025 Surge Still Supported by Valuation?

If you are wondering whether Nuvation Bio's explosive run means you are late to the party or looking at a genuine opportunity, let's break down what the current price might really be worth. The stock has been on a tear recently, with a 75.1% gain over the last month and a 228.6% jump year to date, even after a small 0.8% pullback over the past week. That surge has been fueled by growing optimism around Nuvation Bio's oncology pipeline and increasing investor attention on small cap biotech...
NasdaqGM:VERI
NasdaqGM:VERISoftware

Veritone (VERI): Assessing Valuation After New AI Partnerships in Digital Evidence and Edge-to-Enterprise Data Workflows

Veritone (VERI) has been on traders radar after a flurry of AI focused deals, from powering Strategic Communications JPS TRUST modernization program to teaming with Armada on edge to enterprise data workflows. See our latest analysis for Veritone. Despite a sharp pullback in the latest session, with a 1 day share price return of minus 8.79 percent and the stock closing at 5.19 dollars, Veritone still shows strong positive momentum. This is supported by a 30 day share price return of 20.70...
OM:NEXAM
OM:NEXAMChemicals

3 European Penny Stocks With At Least €90M Market Cap

As the European markets navigate mixed performances, with Germany's DAX showing gains while other major indices like France's CAC 40 and the UK's FTSE 100 experience slight declines, investors are exploring diverse opportunities. Penny stocks, despite their somewhat outdated name, remain a relevant investment area for those interested in smaller or newer companies that may offer surprising value. By focusing on penny stocks with strong financials and potential growth trajectories, investors...
NYSE:DLB
NYSE:DLBSoftware

Does Dolby Present a Long Term Opportunity After Its Recent Share Price Decline?

Wondering if Dolby Laboratories at around $66.62 is quietly turning into a value opportunity, or just a classic value trap in the making? The stock is down 14.4% year to date and 12.9% over the last year, even though it has inched up about 1.6% over the past month. This combination often signals shifting market expectations rather than a simple growth story. Recently, investors have been refocusing on Dolby's role as the audio and imaging standard across cinemas, streaming platforms, and...
SWX:KNIN
SWX:KNINShipping

Is Kuehne and Nagel Fairly Priced After Recent 13.4% Share Price Rebound?

Wondering if Kuehne + Nagel International is quietly turning into a value opportunity, or if the recent interest is just noise? Let us unpack what the current share price is really telling you. After a rough stretch that still leaves the stock down 15.3% year to date and 10.5% over the last year, the shares have bounced with gains of 6.5% in the last week and 13.4% over the past month. Those moves come as investors refocus on global trade normalising, ongoing supply chain recalibration after...
XTRA:ACT
XTRA:ACTChemicals

Is AlzChem Group (XTRA:ACT) Quietly Recasting Its Growth Story Around Creatine Nutrition Demand?

In December 2025, AlzChem Group AG approved a roughly €120 million investment program to build a more automated creatine production plant and related infrastructure, with phased commissioning scheduled from the second half of 2027 to capture additional demand in sports, food, and health. The company links this capacity expansion to early triple-digit million euro annual sales potential from its Creapure® and Creavitalis® lines, underscoring how nutrition and wellness trends are reshaping its...
NYSE:RYN
NYSE:RYNSpecialized REITs

What Rayonier (RYN)'s Special Dividend and New Shelf Registration Mean For Shareholders

In October 2025, Rayonier Inc. declared a special dividend of US$1.40 per common share, which was paid on December 12, 2025, and subsequently filed an omnibus shelf registration covering multiple securities, including debt, common and preferred shares, warrants, subscription rights, stock purchase contracts, and units. This combination of an immediate cash return to shareholders and expanded flexibility to raise capital in the future reflects Rayonier’s twin focus on rewarding investors...